RE:RE:RE:My rough math with assumptions I seem to recall. Dr. Kulkarni said in a video that 30% would be considered "phenomenal". We are at 28% with half of the participants having the wrong dose. I would say that qualifies us for that 30%. Happy to see him presenting the company at the conferences.
One thing I do ponder. Since the last update with treated patients, there have been new patients treated since that, right?